3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Serotonin Syndrome
3
Neuroendocrine Tumors
3
Pancreatic Neoplasms
1
Diarrhea
1
Carcinoid Tumor
1
Biliary Tract Neoplasms
1
Interventions
Octreotide
2
telotristat ethyl
1
isatuximab
1
ceterizine hydrochloride
1
capivasertib
1
cabazitaxel
1
XRP6258
1
Prednisone
1
Loperamide
1
Leucovorin
1
Lapatinib
1
Irinotecan
1
Injections
1
Granulocyte Colony-Stimulating Factor
1
Fulvestrant
1
Fluorouracil
1
Filgrastim
1
Drugs, Investigational
1
Cyclophosphamide
1
Colesevelam Hydrochloride
1
Cell- and Tissue-Based Therapy
1
Capecitabine
1
Calcium Aluminosilicate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Diarrhea
×
telotristat ethyl
×
Clear all
NCT04713202
2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2
Withdrawn